scholarly article | Q13442814 |
P50 | author | Kara Cox | Q88400972 |
Gokul Swaminathan | Q117535977 | ||
P2093 | author name string | Andrew J Bett | |
Danilo R Casimiro | |||
Elizabeth A Thoryk | |||
Steven Meschino | |||
Marian Gindy | |||
P2860 | cites work | Engineering synthetic vaccines using cues from natural immunity | Q38154804 |
A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens | Q38944133 | ||
AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity | Q39782280 | ||
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses | Q41736997 | ||
Mechanism of immunopotentiation and safety of aluminum adjuvants. | Q42036323 | ||
Immunogenicity of a reduced-dose whole killed rabies vaccine is significantly enhanced by ISCOMATRIX™ adjuvant, Merck amorphous aluminum hydroxylphosphate sulfate (MAA) or a synthetic TLR9 agonist in rhesus macaques | Q42276948 | ||
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity | Q43638130 | ||
Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration | Q45264739 | ||
Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles | Q45289233 | ||
Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics | Q47430410 | ||
The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. | Q47809273 | ||
Quantification of antigen specific CD8+ T cells using an ELISPOT assay | Q47999428 | ||
Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response. | Q50560920 | ||
Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers. | Q51019872 | ||
A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice | Q58827824 | ||
Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants | Q79172680 | ||
Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response | Q80754925 | ||
Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response | Q82910116 | ||
Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response | Q85278186 | ||
Adjuvants: Classification, Modus Operandi, and Licensing | Q26747586 | ||
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy | Q26782566 | ||
Molecular signatures of vaccine adjuvants | Q26865514 | ||
A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates | Q27116692 | ||
Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist | Q30573156 | ||
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review | Q30656373 | ||
Unmet needs in modern vaccinology: adjuvants to improve the immune response | Q34131456 | ||
Antigen depot is not required for alum adjuvanticity | Q34235031 | ||
Mechanisms of stimulation of the immune response by aluminum adjuvants | Q34787679 | ||
A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing | Q36711264 | ||
The perfect mix: recent progress in adjuvant research | Q36844715 | ||
Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens | Q37191759 | ||
Cellular interactions of therapeutically delivered nanoparticles | Q37827166 | ||
Alum adjuvant: some of the tricks of the oldest adjuvant | Q37969028 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P577 | publication date | 2016-12-06 | |
P1433 | published in | Vaccines | Q27725508 |
P1476 | title | Co-Administration of Lipid Nanoparticles and Sub-Unit Vaccine Antigens Is Required for Increase in Antigen-Specific Immune Responses in Mice | |
P478 | volume | 4 |